Study number 8530-629
1 stay of 17 nights & 1 follow-up visit
Dates
Apr 24 2024-May 18 2024
Location
Dallas, Texas
Age
18-55
Gender
Both
Smoker
Compensation
$6,802
Group
Part B
Study Details
The purpose of this study is to measure how much of the study drug and its breakdown products get into the blood stream and how long it takes the body to get rid of them, when given with amoxicillin/clavulanic acid. Amoxicillin/clavulanic acid is an approved antibotic for the treatment of certain types of bacterial infections. In addition, the safety and tolerability of the study drug will be evaluated when given alone, and in combination with amoxicillin/clavulanic acid.
Fortrea Dallas, TX is recruiting for:
-Healthy Non-smoking Men and Women, age 18-55
-Body Mass Index between 18-30.5
-Study involves 1 stay of 17 nights & 1 follow-up visit
-Compensation up to $6,802 may be provided for time and participation
-Refer a friend to receive $350 per qualified referral
Additional Details
Part B:
Check-in: Apr 24
Check-out: May 11
Outpatient visit: May 18